“Jami is an industry-leading intellect and advisor to transformational healthcare companies,” said Mark Van Lith, CEO of Guggenheim Securities. “Jami is an important addition to our premier healthcare ...
First Stamford Place is the new home of Guggenheim Partners' Connecticut office. Photo courtesy of Newmark Group STAMFORD – The ...
Guggenheim Strategic Opportunities Fund (NYSE:GOF – Get Free Report) declared a monthly dividend on Thursday, January 2nd,Wall Street Journal reports. Stockholders of record on Wednesday, January 15th ...
NEW YORK, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Guggenheim Investments today announced that certain closed-end funds have declared their distributions. The table below summarizes the distribution schedule ...
Mr. Bookin retired from Guggenheim Partners ($300 billion AUM) after a decade as a Managing Director in the Corporate Credit Group based in New York City and Los Angeles. In his role, Mr. Bookin ...
Guggenheim Partners expanded its coverage on the bioprocessing industry on Thursday, granting Buy recommendations for Danaher (NYSE:DHR), Cryoport (NASDAQ:CYRX), and Sartorius (OTCPK:SARTF ...
Fintel reports that on January 7, 2025, Guggenheim downgraded their outlook for Palo Alto Networks (NasdaqGS:PANW) from ...
Weight-loss drug developer Metsera, backed by ARCH Venture Partners, revealed a wider loss in its paperwork for a U.S.